1[1]Chobanian AV, Bakris GL, Black HR, et al.The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation,and Treatment of High Blood Pressure: the JNC 7 report [J ] .JAMA,2003,289(20) :2560 ～ 72.
2[2]Kidney Disease Outcomes Quality Initiative ( K/DOQI ) .K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease[J] .Am J Kidney Dis, 2004, 43(Suppl 1 ) :S1 ～ 290.
3[3]Flack JM, Peters R, Shafi T, et al.Prevention of hypertension and its complications: theoretical basis and guidelines for treatment [J]. J Am Soc Nephrol,2003,14(Suppl 2):S92～8.
5[5]Klag MJ, Whelton PK, Randall BL, et al. End-stage renal disease in African-American and white men 16 year MRFIT findings [J] .JAMA,1997, 277(16): 1293 ～ 8.
6[6]Bakris GL, Weir MR, Shanifar S, et al. Effects of blood pressure level on progression of diabetic nephropathy: Results from the RENAAL study [ J ]. Arch Intern Med, 2003, 63 (12): 1555 ～ 65.
7[7]Burt VL, Cutler JA, Higgins M, et al.Trends in the prevalence,awareness, treatment, and control of hypertension in the adult US population. Data from the health examination surveys, 1960 to 1991[J]. Hypertension, 1995, 26( 1 ) :60 ～ 9.
8[8]Levin A, Singer J, Thompson CR, et al.Prevalent left ventricular hypertrophy in the predialysis population:identifying opportunities for intervention[J] .Am J Kidney Dis, 1996, 27(2) :347 ～ 54.
9[9]Foley RN, Parfrey PS, Harnett JD,et al.Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal disease[J]. Kidney Int, 1996,49(4): 1379 ～ 85.
10[10]Kasiske BL, Kalil RSN, Ma JZ, et al.Effect of antihypertensive therapy on the kidney in patients with diabetes: A meta-regression analysis[J] .Ann Intern Med, 1993,118(2): 129 ～ 38.
